Model Number PVS23 |
Device Problems
Gradient Increase (1270); Material Too Rigid or Stiff (1544)
|
Patient Problems
Aortic Insufficiency (1715); Aortic Valve Stenosis (1717); Calcium Deposits/Calcification (1758); Cardiac Arrest (1762); Cardiogenic Shock (2262)
|
Event Date 04/24/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
Device not explanted.
|
|
Event Description
|
The manufacturer received information about this event through the (b)(6) study database.On (b)(6) 2012, a (b)(6) years old male patient received a perceval pvs23 in aortic position.The procedure was performed in mini-thoracotomy and no concomitant procedures occurred.At discharge, the echo showed a mean gradient of 15mmhg and no central/perivalvular leaks.On (b)(6) 2015, a structural valve deterioration was identified.It is reported that the leaflet appeared stiffened (calcified), resulting in a steno-insufficiency of the device.The patient was symptomatic.About one month later, on (b)(6) 2015, the patient had a cardiogenic shock followed by cardiac arrest.On (b)(6) 2015, a re-intervention occurred due to structural valve deterioration of the device.A valve-in-valve procedure was performed.Prior to the event, the last available information on the device functionality is in (b)(6) 2013; the echo performed showed a mean gradient of 14mmhg and no central/perivalvular leaks.
|
|
Manufacturer Narrative
|
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.
|
|
Manufacturer Narrative
|
Since the device was not explanted, no further device analysis can be performed.As such, the root cause of the event cannot be determined at this time.It could be possible, as also confirmed by the site, that the patient's renal insufficiency contributed to the reported structural valve deterioration.However, this cannot be confirmed due to the limited investigation performed, and the root cause remains ultimately unknown.It should be noted that structural valve deterioration is a known inherent risk associated with cardiac valve replacement with a bioprosthesis, and is listed among the potential adverse events in the perceval instructions for use.
|
|
Event Description
|
The manufacturer received information about this event through the sure avr study database.On (b)(6) 2012, a 71 years old male patient received a perceval pvs23 in aortic position.The procedure was performed in mini-thoracotomy and no concomitant procedures occurred.At discharge, the echo showed a mean gradient of 15mmhg and no central/perivalvular leaks.A good valve functionality was also observed in nov 2013 (mean gradient of 14mmhg, no leaks) on 24 apr 2015, a structural valve deterioration was identified.It is reported that the leaflet appeared stiffened (calcified), resulting in a steno-insufficiency of the device.The patient was symptomatic.About one month later, on (b)(6) 2015, the patient had a cardiogenic shock followed by cardiac arrest.On (b)(6) 2015, a re-intervention occurred due to structural valve deterioration of the device.A valve-in-valve procedure was performed, without any complication.The patient moved to another hospital in good conditions.The site reported that the may have been a relationship between the patient's renal insufficiency and the reported structural valve deterioration.
|
|
Search Alerts/Recalls
|
|